Hani Hamade

Dr. Hani Hamade


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2023 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
HHHani Hamade
Hani Hamade
AJAhmad Jabri
Ahmad Jabri
PMPooja Mishra
Pooja Mishra
MBMuhammad Umer Butt
Muhammad Umer Butt
SSSherin Sallam
Sherin Sallam
SKSaima Karim
Saima Karim
Introduction: Female patients, patients from racial minorities, and patient with low socioeconomic status have been noted to have less access to catheter ablation for atrial fibrillation.Methods: This is a cross-sectional, retrospective study using a large population database (Explorys) to evaluate the gender, racial and socioeconomic differences in access of catheter ablation therapy in patient with atrial fibrillation.Results: A total of 2.2 million patients were identified as having atrial fibrillation and 62,760 underwent ablation. Females had ablation in 2.1% of cases while males received ablation in 3.4% of cases. Caucasians had ablation in 3.3% of cases, African Americans in 1.5% of cases and other minorities in 1.2% of cases. Individuals on medicaid underwent ablation in 1.6% of cases, individuals on medicare and private insurance had higher rates (2.8 and 2.9%, respectively). Logistic regression showed that female patients (OR 0.608, CI 0.597–0.618, p < 0.0001), patients who are African American (OR 0.483, CI 0.465–0.502, p < 0.0001), or from other racial minorities (OR 0.343, CI 0.332–0.355, p < 0.0001) were less likely to undergo ablation. Patient with medicare (OR 1.444, CI 1.37–1.522, p < 0.0001) and private insurance (OR 1.572, CI 1.491–1.658, p < 0.0001) were more likely to undergo ablation.Conclusion: Female gender, racial minorities, low socioeconomic status are all associated with lower rates of catheter ablation in management of atrial fibrillation.

14 January 2020 in Clinical Toxicology
Verified
Journal Article
Closed access
EHEveline Hitti
Eveline Hitti
TZTharwat El Zahran
Tharwat El Zahran
HHHani Hamade
Hani Hamade
RKRima Kaddoura
Rima Kaddoura
ZMZeina Mneimneh
Zeina Mneimneh
ZKZiad Kazzi
Ziad Kazzi
Introduction: This study aims to describe the epidemiology of toxicological exposures reported to a telephonic medical toxicology service at a tertiary care center in Lebanon during a 46-months period. Methods: This study is a secondary analysis of a database for a telephonic medical toxicology service at a tertiary care center in Lebanon. Clinical information from all pediatric and adult patients, presenting with intentional or unintentional toxicological exposure, was entered into the database by the medical toxicology team. Results: Four hundred and seventy-seven exposures were recorded from 1 March 2015 to 31 December 2018. Female patients were involved in 60.2% of cases. Children less than 5 years old constituted 23.5% of cases and adults aged 20–49 constituted 48.6%. Up to 51.6% of cases were intentional, with 37.7% resulting from suicidal attempts. The majority of patients displayed no effects (33.1%) or minor effects (39.2%). Almost half of patients were treated and discharged from the Emergency Department (ED) without further hospitalization, and another 18.9% of patients left the ED against medical advice. The most common pharmaceutical agents involved were sedative/hypnotics/antipsychotics (14.7%), analgesics (12.6%) and antidepressants (11.3%). The most common non-pharmaceutical agents involved were household cleaning substances (8.0%), pesticides (5.2%) and bites and envenomations (3.8%). Conclusions: The results of this study suggest that sedative/hypnotics/antipsychotics, analgesics, antidepressants and household cleaning substances are the most common agents involved. Adult women and children ≤5 years old constitute a large portion of patients with toxicological exposures. Prevention strategies and policies should be implemented to mitigate these hazards.

15 April 2021 in Contemporary Clinical Trials Communications
Verified
Journal Article
Open access
AEAbbass El-Outa
Abbass El-Outa
LGLara Ghandour
Lara Ghandour
HHHani Hamade
Hani Hamade
CBCecile Borgi
Cecile Borgi
Elie Jacques FaresElie Jacques Fares
Elie Jacques Fares
AMAfif Mufarrij
Afif Mufarrij
There is increasing evidence from animal and human studies suggesting that fasting can play a role in disease prevention, weight control and longevity. However, few studies have compared exercise performances in individuals adhering to an intermittent fasting (IF) in comparison to individuals who are not. Given the rising popularity of IF we aim to investigate whether this type eating pattern will improve cardiovascular performance over a period of 12 weeks through VO2 max measurements in participants from a Lebanese community. Additionally, we will study the variation of different health parameters, physical performance and biomarkers potentially affected by IF. Participants will be recruited from a large university community and randomized into 4 arms. Baseline information will be collected from all participants, which includes biological, physical, nutritional, medical and psychological data. Two arms will follow a time-restricted fasting diet with and without physical exercise, one arm will exercise without fasting, and one will act as a control group. Throughout the study, measurements will be repeated, and data analysis will follow to evaluate results.

4 June 2022 in Current Problems in Cardiology
Verified
Journal Article
Closed access
AJAhmad Jabri
Ahmad Jabri
LALaith Alhuneafat
Laith Alhuneafat
PRPejman Raeisi-Giglou
Pejman Raeisi-Giglou
YNYassar Nabeel
Yassar Nabeel
HHHani Hamade
Hani Hamade
AAAshish Aneja
Ashish Aneja

26 October 2026 in European Heart Journal - Valvular and Structural Heart Disease
Verified
Journal Article
Open access
KLKevin Lai
Kevin Lai
GFGeorgi K Fram
Georgi K Fram
JDJohn Dawdy
John Dawdy
JAJames Alter
James Alter
HHHani Hamade
Hani Hamade
JLJames C Lee
James C Lee
Background: Edwards EVOQUE system is a transcatheter tricuspid valve replacement (TTVR) option designed for right transfemoral access, however, suboptimal valve positioning and delivery occurs in patients with unfavorable anatomy. When considering alternative access, early uses of left internal jugular (LIJ) access has seen procedural success and hosts advantageous mechanisms that are poorly understood. Aims: To understand the mechanism of LIJ approach by developing a mechanistic framework that demonstrates the geometric advantages compared to right internal jugular (RIJ) and how it can improve EVOQUE valve positioning and delivery Methods and results: Retrospective analysis of 24 patients (LIJ = 13, RIJ = 11) who underwent successful TTVR procedure between June 2024 and September 2025. Multimodality analysis combining echocardiography, cardiac computed tomography and fluoroscopy was performed to analyze delivery system positions LIJ demonstrated larger delivery system distance to septal wall (16.6 ± 5.3 mm) than RIJ (9.5 ± 3.5 mm)(P < 0.001) and was similarly observed at 10 mm and 20 mm proximal points, across 3 time points as validated by transesophageal echocardiography septal distances to delivery system. Trajectory of delivery system averaged LIJ = 17.8 ± 4.8° vs RIJ = 2.3 ± 2.8° (P < 0.010). LIJ primary flexion angle on average was larger at 82.0 ± 14.1° vs 57.2 ± 21.8°, P = 0.003. CT 3D modeling estimated larger average distance of delivery system to septal plane for LIJ (24.4 ± 9.1 mm vs 19.3 ± 7.3 mm) and length of primary flexion to tricuspid annulus (52.4 ± 8.0 mm vs 44.4 ± 5.7mm, P < 0.05). Conclusions: In this single-centre experience, LIJ access facilitated more central placement of EVOQUE delivery system in the septal-lateral tricuspid annular plane and improved trajectory alignment in TTVR with EVOQUE which correlated with comparable procedure times and safety compared to other access choices. While these findings offer a mechanistic rationale for LIJ access in selected patients, larger prospective multi-centre studies are required to confirm clinical superiority and refine patient selection criteria.

15 December 2025 in JACC: Case Reports
Verified
Journal Article
Open access
TFTiberio M. Frisoli
Tiberio M. Frisoli
HHHani Hamade
Hani Hamade
FSFares Sukhon
Fares Sukhon
JLJames Lee
James Lee
JDJohn Dawdy
John Dawdy
MAMohammad Alqarqaz
Mohammad Alqarqaz
The JenaValve Trilogy transcatheter heart valve (THV) is a percutaneous treatment modality for severe aortic regurgitation. The device is designed to offer stability and lower risk of device migration and coronary occlusion. A 59-year-old woman with severe aortic regurgitation underwent implantation of the JenaValve THV. After discharge, the patient presented with acute coronary syndrome. Evaluation revealed a left main coronary thrombus and intermittent obstruction of the left coronary ostium by the native aortic valve leaflet. This case describes the first reported incidence of coronary artery thrombosis after deployment of the JenaValve Trilogy THV, and the role of multimodal imaging in understanding the diagnosis and complex intervention planning. Aortic valve leaflet obstruction and coronary artery thrombosis are rare complications of JenaValve THV implantation for aortic regurgitation. Multimodal imaging is essential in the diagnosis and management of these complications.